NMPA Approval

Electrolytes and Glucose Composition Injection-R4A

Approval Number

国药准字H20227084

Company广东大冢制药有限公司

Registration Date

June 28, 2022

Previous Approval Numbers

国药准字H44020182

Drug Information

Generic Name

复方电解质葡萄糖注射液-R4A

Dosage Form

注射剂

Strength

100ml

Drug Type

化学药品

Registration Date

June 28, 2022

Company Information

Applicant Company

Company Name广东大冢制药有限公司

Company Address

广东省佛山市顺德区容桂街道市高新技术产业开发园

Manufacturing Company

Company Name广东大冢制药有限公司

Company Address

广东省佛山市顺德区容桂街道市高新技术产业开发园

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

复方电解质葡萄糖注射液-R4A - NMPA 批准文号 | MedPath